SE448679B - Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin - Google Patents

Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin

Info

Publication number
SE448679B
SE448679B SE7907316A SE7907316A SE448679B SE 448679 B SE448679 B SE 448679B SE 7907316 A SE7907316 A SE 7907316A SE 7907316 A SE7907316 A SE 7907316A SE 448679 B SE448679 B SE 448679B
Authority
SE
Sweden
Prior art keywords
cancer
amino acid
solution
free
amino acids
Prior art date
Application number
SE7907316A
Other languages
English (en)
Swedish (sv)
Other versions
SE7907316L (sv
Inventor
K Ozeki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE7907316L publication Critical patent/SE7907316L/
Publication of SE448679B publication Critical patent/SE448679B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SE7907316A 1978-09-04 1979-09-03 Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin SE448679B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
SE7907316L SE7907316L (sv) 1980-03-05
SE448679B true SE448679B (sv) 1987-03-16

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7907316A SE448679B (sv) 1978-09-04 1979-09-03 Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin

Country Status (10)

Country Link
JP (1) JPS5535049A (fr)
AU (1) AU526207B2 (fr)
CA (1) CA1134275A (fr)
CH (1) CH642541A5 (fr)
DE (1) DE2935709C2 (fr)
FR (1) FR2434622A1 (fr)
GB (1) GB2029220B (fr)
IT (1) IT1194844B (fr)
NL (1) NL190266C (fr)
SE (1) SE448679B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003552A1 (fr) * 1981-04-17 1982-10-28 Hospital Supply Corp American Solution amelioree pour nutrition par voie parenterale
FR2508797B1 (fr) * 1981-07-03 1986-03-14 Charles Chany Medicament comprenant le produit de la reaction d'un acide carboxylique en c1 a c6 sur un amino-acide basique
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
CA2097196C (fr) * 1991-10-07 1999-04-13 Shozo Aoi Preparation enterale pour le traitement du cancer
DE4228897A1 (de) * 1992-08-29 1994-03-03 Wella Ag Mittel zur Festigung der Haare auf der Basis von Lignin oder Ligninderivaten sowie Dihydroxypropyllignin
EP0668933B1 (fr) * 1992-11-19 2002-10-02 Anticancer, Inc. Utilisation de methioninase comme agent anti-tumoral dans la chimiotherapie anti-methionine
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
WO1998004255A1 (fr) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Composition a base d'acides amines et utilisation de celle-ci dans le traitement de la croissance tumorale et des metastases
EP1068868A3 (fr) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Compositions synergiques comportant l'ascorbate et la lysine pour des états associés à la dégénération de la matrice extracellulaire
EP1163904B1 (fr) * 2000-06-16 2006-04-19 Rath, Matthias, Dr. med. Composition pour la prévention des maladies de muscle lise comprenant l'ascorbate, l'arginine et le magnésium
EP1195159B1 (fr) * 2000-10-09 2006-05-31 Rath, Matthias, Dr. med. Combinaison thérapeutique d'ascorbate avec de la lysine et de l'arginine pour la prévention et le traitement du cancer
CH694549A5 (de) 2001-01-16 2005-03-31 Dr Matthias Rath Verwendung einer synergistischen Zusammensetzung, die Ascorbat und Lysin für Zustände enthält zur Behandlung extrazellularer Matrixdegeration.
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (fr) * 2001-10-05 2003-04-17 Tetsuro Asao Activateurs du systeme immunitaire
US20030105104A1 (en) 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US20070258969A1 (en) * 2004-03-19 2007-11-08 Eliezer Zomer Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
WO2007016949A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition réduisant les risques de neuropathie induite par l’alcool
WO2007016951A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition réduisant les risques de cancer du pancréas induit par l’alcool
WO2007016950A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition réduisant les risques de maladie neurodégénérative induite par l’alcool
WO2007016952A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition réduisant les risques de cancer de l’oesophage ou de l’oropharyngolaryngée induit par l’alcool
WO2007016955A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition modérant le métabolisme de l’alcool
EA012753B1 (ru) * 2005-07-29 2009-12-30 Тима Фаундейшн Композиция для сдерживания алкогольного метаболизма и для уменьшения риска заболеваний, вызванных алкоголем
WO2007016954A1 (fr) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition réduisant les risques de cancer du sein induit par l’alcool ou les médicaments
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
WO2008119077A1 (fr) 2007-03-28 2008-10-02 University Of Southern California Induction d'une résistance différentielle au stress et utilisations de celle-ci
EP2285218B1 (fr) * 2008-04-24 2020-06-17 University Of Southern California, USC Stevens Compositions alimentaires et procédés pour la protection contre la chimiothérapie ou la radiothérapie
CN103347511B (zh) * 2011-02-17 2016-04-27 味之素株式会社 化学治疗剂的抗肿瘤活性的增强剂
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
TWI775921B (zh) 2017-08-14 2022-09-01 美商胺細拉健康公司 用於治療和高血氨症或肌肉耗損中之一者或兩者相關之肝疾病及失調之組合物及方法
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (fr) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung

Also Published As

Publication number Publication date
CH642541A5 (de) 1984-04-30
AU526207B2 (en) 1982-12-23
NL7906620A (nl) 1980-03-06
DE2935709A1 (de) 1980-03-13
SE7907316L (sv) 1980-03-05
NL190266C (nl) 1994-01-03
CA1134275A (fr) 1982-10-26
FR2434622B1 (fr) 1983-04-15
JPS5535049A (en) 1980-03-11
DE2935709C2 (de) 1986-02-06
GB2029220A (en) 1980-03-19
AU5036879A (en) 1980-03-13
NL190266B (nl) 1993-08-02
FR2434622A1 (fr) 1980-03-28
GB2029220B (en) 1983-03-30
JPS6154007B2 (fr) 1986-11-20
IT1194844B (it) 1988-09-28
IT7905216A0 (it) 1979-09-03

Similar Documents

Publication Publication Date Title
SE448679B (sv) Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin
Laszlo et al. Effects of glucose analogues (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors
Czyzyk et al. Effect of biguanides on intestinal absorption of glucose
KR100861889B1 (ko) 중환자, 만성 질환자 및 영양실조인 사람의 비경구 영양공급 또는 부분 장내/경구 영양 공급을 위해 장내투여되는 보충제
JP6130666B2 (ja) １種以上のクレアチン化合物を含んでなる血液透析液及び腹膜透析液
GB2113524A (en) Elemental diets for liver diseases
EP0547099B1 (fr) Produit contenant un facteur de croissance et de la glutamine et utilisation d'un facteur de croissance dans le traitement des muqueuses intestinales
SE459900B (sv) Aminosyrakomposition foer behandling av njursvikt
SE464796B (sv) Komposition avsedd att minska oeverviktstillstaand hos daeggdjur innehaallande pyruvat och dihydroxiaceton
US11129843B2 (en) Treating and preventing kidney damage
KR20110120981A (ko) 간암 발생 및 진행 억제제
WO1994022439A1 (fr) Administration orale de glutamine pour limiter les cas de stomatite
JPH1036260A (ja) 抗ガン剤の効力増強方法
US6797729B1 (en) Therapeutic glutamine and N-actyl-cysteine composition
KR20180101460A (ko) 근육의 보호에서 시스탄케 투불로사 추출물 및 이소악테오사이드의 용도
RU2314824C2 (ru) Препаративная готовая форма для гастроинтестинального введения и ее применение
JP2648176B2 (ja) 制癌剤
JP5065555B2 (ja) コリン配合輸液剤
US5008287A (en) Pharmaceutical compositions having antineoplastic activity
EP0348664A2 (fr) Compositions pharmaceutiques contenant des monoacétoacétines pour le traitement des tumeurs
EP1062946A1 (fr) Medicaments preventifs et curatifs de troubles de la muqueuse intestinale
JPH0534338B2 (fr)
MXPA97006140A (en) Compositions of amino acids and the use of them in nutrition clin
Munder Lysolecithin and its analogs
JPH05186354A (ja) 抗癌剤及び免疫賦活剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7907316-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907316-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7907316-9

Format of ref document f/p: F